Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
Christmas Patrick J.Chief Legal Officer
|
Tax withholdingCommon Stock | 11,395 | $7.73 | $88,083.35 |
DisclosureSEC source: 0001562180-25-000186 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,810 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:59 UTC |
Chan MitchellChief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 62,547 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001562180-25-000187 · primarydocument.xml · derivative · entry 1 Chan Mitchell · CIK 0001789335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,547 Underlying: Common Stock · 62,547 shares Expires 2035-01-02 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2025 Filed Jan 14, 2025 22:19 UTC Amendment |
Simpson CurranDirector · Chief Executive Officer
|
GrantStock Options (Right to buy) · Derivative | 478,606 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001562180-25-000360 · primarydocument.xml · derivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,606 Underlying: Common Stock · 478,606 shares Expires 2035-01-02 F1 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:31 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-007144 · primarydocument.xml · derivative · entry 3 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to the option vested on May 19, 2015, and the balance vested equal installments over the next 24 months. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:31 UTC |
KARABELAS ARGERIS NDirector
|
SaleCommon Stock | 10,000 | $10.11 | $101,052.00 |
DisclosureSEC source: 0001562180-24-007144 · primarydocument.xml · nonDerivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $10.01 to $10.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:31 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionCommon Stock | 10,000 | $3.76 | $37,600.00 |
DisclosureSEC source: 0001562180-24-007144 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:04 UTC |
Chan MitchellChief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 289,362 | $0.00 Strike: $12.74 | $0.00 |
DisclosureSEC source: 0001562180-24-006869 · primarydocument.xml · derivative · entry 2 Chan Mitchell · CIK 0001789335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,362 Underlying: Common Stock · 289,362 shares Expires 2034-09-16 F2 · derivative.exercise_date: The option vesting commencement date shall be September 16, 2024. The options shall have a term of 10 years from the date of grant, subject to continuous service of the optionee to the Issuer. The options shall become exercisable as follows: with respect to 1/4th of the shares subject to the option when the optionee completes 12 months of continuous service to the Issuer after the vesting commencement date, and with respect to 1/48th of the shares subject to the option when the optionee completes each month of continuous service to the Issuer thereafter. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:04 UTC |
Chan MitchellChief Financial Officer
|
GrantCommon Stock | 58,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006869 · primarydocument.xml · nonDerivative · entry 1 Chan Mitchell · CIK 0001789335 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,869 F1 · shares: The restricted stock unit (RSU) award vesting commencement date shall be September 16, 2024. 1/4th of the shares subject to the RSU shall vest on each of the first, second, third and fourth anniversaries of the first day of the month in which the RSU was granted, subject to the continuous service of the recipient to the Issuer. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:20 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-006657 · primarydocument.xml · derivative · entry 4 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to the option vested on May 19, 2015, and the balance vested equal installments over the next 24 months. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:20 UTC |
KARABELAS ARGERIS NDirector
|
SaleCommon Stock | 700 | $12.34 | $8,638.00 |
DisclosureSEC source: 0001562180-24-006657 · primarydocument.xml · nonDerivative · entry 3 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $12.24 to $12.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:20 UTC |
KARABELAS ARGERIS NDirector
|
SaleCommon Stock | 9,300 | $11.50 | $106,950.00 |
DisclosureSEC source: 0001562180-24-006657 · primarydocument.xml · nonDerivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,986 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $11.24 to $12.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:20 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionCommon Stock | 10,000 | $3.76 | $37,600.00 |
DisclosureSEC source: 0001562180-24-006657 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:58 UTC |
Mills Kenneth T.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 36,316 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-24-006146 · primarydocument.xml · derivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,316 shares Expires 2024-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:58 UTC |
Mills Kenneth T.Director
|
Exercise / conversionCommon Stock | 36,316 | $0.85 | $30,868.60 |
DisclosureSEC source: 0001562180-24-006146 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 18:38 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 58,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006013 · primarydocument.xml · nonDerivative · entry 2 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,083 F3 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of February 1, 2025, August 1, 2025, February 1, 2026 and August 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:41 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantCommon Stock | 58,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006017 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,578 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of February 1, 2025, August 1, 2025, February 1, 2026 and August 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-006015 · primarydocument.xml · derivative · entry 7 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to the option vested on May 19, 2015, and the balance vested equal installments over the next 24 months. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 100 | $0.00 Strike: $12.74 | $0.00 |
DisclosureSEC source: 0001562180-24-006015 · primarydocument.xml · derivative · entry 6 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 100 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
KARABELAS ARGERIS NDirector
|
SaleCommon Stock | 100 | $15.00 | $1,500.00 |
DisclosureSEC source: 0001562180-24-006015 · primarydocument.xml · nonDerivative · entry 5 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
KARABELAS ARGERIS NDirector
|
SaleCommon Stock | 400 | $14.59 | $5,834.00 |
DisclosureSEC source: 0001562180-24-006015 · primarydocument.xml · nonDerivative · entry 4 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,386 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $14.44 to $14.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
KARABELAS ARGERIS NDirector
|
SaleCommon Stock | 9,600 | $13.45 | $129,120.00 |
DisclosureSEC source: 0001562180-24-006015 · primarydocument.xml · nonDerivative · entry 3 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,786 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.20 to $14.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionCommon Stock | 100 | $12.74 | $1,274.00 |
DisclosureSEC source: 0001562180-24-006015 · primarydocument.xml · nonDerivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionCommon Stock | 10,000 | $3.76 | $37,600.00 |
DisclosureSEC source: 0001562180-24-006015 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
Simpson CurranDirector · Chief Executive Officer
|
SaleCommon Stock | 100 | $15.00 | $1,500.00 |
DisclosureSEC source: 0001562180-24-006014 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170,037 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan as adopted on March 15, 2024. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 22:39 UTC |
Christmas Patrick J.Chief Legal Officer
|
GrantCommon Stock | 56,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006016 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,205 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of February 1, 2025, August 1, 2025, February 1, 2026 and August 1, 2026 while the recipient provides continuous service to the Issuer. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 21:01 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $12.74 | $0.00 |
DisclosureSEC source: 0001562180-24-005875 · primarydocument.xml · derivative · entry 3 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 11,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 21:01 UTC |
KARABELAS ARGERIS NDirector
|
SaleCommon Stock | 11,000 | $15.05 | $165,495.00 |
DisclosureSEC source: 0001562180-24-005875 · primarydocument.xml · nonDerivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 21:01 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionCommon Stock | 11,000 | $12.74 | $140,140.00 |
DisclosureSEC source: 0001562180-24-005875 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 21:01 UTC |
Simpson CurranDirector · Chief Executive Officer
|
SaleCommon Stock | 9,648 | $15.04 | $145,105.92 |
DisclosureSEC source: 0001562180-24-005874 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170,137 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 21:00 UTC |
Mills Kenneth T.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 15,369 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-005855 · primarydocument.xml · derivative · entry 6 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,354 Underlying: Common Stock · 15,369 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 21:00 UTC |
Mills Kenneth T.Director
|
SaleCommon Stock | 15,369 | $13.96 | $214,500.52 |
DisclosureSEC source: 0001562180-24-005855 · primarydocument.xml · nonDerivative · entry 4 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $13.76 to $14.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 21:00 UTC |
Mills Kenneth T.Director
|
Exercise / conversionCommon Stock | 15,369 | $3.76 | $57,787.44 |
DisclosureSEC source: 0001562180-24-005855 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 423,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 21:00 UTC |
Mills Kenneth T.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 12,221 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-005855 · primarydocument.xml · derivative · entry 5 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,723 Underlying: Common Stock · 12,221 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 21:00 UTC |
Mills Kenneth T.Director
|
SaleCommon Stock | 12,221 | $13.78 | $168,433.49 |
DisclosureSEC source: 0001562180-24-005855 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.76 to $13.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 21:00 UTC |
Mills Kenneth T.Director
|
Exercise / conversionCommon Stock | 12,221 | $3.76 | $45,950.96 |
DisclosureSEC source: 0001562180-24-005855 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 420,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 17, 2024 Filed Jul 18, 2024 21:05 UTC |
Mills Kenneth T.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 2,210 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-005798 · primarydocument.xml · derivative · entry 6 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,944 Underlying: Common Stock · 2,210 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| July 17, 2024 Filed Jul 18, 2024 21:05 UTC |
Mills Kenneth T.Director
|
SaleCommon Stock | 2,210 | $13.77 | $30,439.88 |
DisclosureSEC source: 0001562180-24-005798 · primarydocument.xml · nonDerivative · entry 4 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.76 to $13.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 17, 2024 Filed Jul 18, 2024 21:05 UTC |
Mills Kenneth T.Director
|
Exercise / conversionCommon Stock | 2,210 | $3.76 | $8,309.60 |
DisclosureSEC source: 0001562180-24-005798 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 410,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 21:05 UTC |
Mills Kenneth T.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 200 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-005798 · primarydocument.xml · derivative · entry 5 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,154 Underlying: Common Stock · 200 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 21:05 UTC |
Mills Kenneth T.Director
|
SaleCommon Stock | 200 | $13.76 | $2,752.00 |
DisclosureSEC source: 0001562180-24-005798 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,035 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 21:05 UTC |
Mills Kenneth T.Director
|
Exercise / conversionCommon Stock | 200 | $3.76 | $752.00 |
DisclosureSEC source: 0001562180-24-005798 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 11:55 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-24-005566 · primarydocument.xml · derivative · entry 3 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 24 months thereafter. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 11:55 UTC |
KARABELAS ARGERIS NDirector
|
SaleCommon Stock | 10,000 | $11.27 | $112,691.00 |
DisclosureSEC source: 0001562180-24-005566 · primarydocument.xml · nonDerivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,286 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $10.98 to $11.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 11:55 UTC |
KARABELAS ARGERIS NDirector
|
Exercise / conversionCommon Stock | 10,000 | $3.76 | $37,600.00 |
DisclosureSEC source: 0001562180-24-005566 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 11:56 UTC |
Simpson CurranDirector · Chief Executive Officer
|
GrantStock Options (Right to Buy) · Derivative | 272,189 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001562180-24-005567 · primarydocument.xml · derivative · entry 2 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,189 Underlying: Common Stock · 272,189 shares Expires 2034-07-01 F2 · derivative.exercise_date: The option vesting commencement date shall be July 1, 2024. The options shall have a term of 10 years from the date of grant, subject to continuous service of the optionee to the Issuer. The options shall become exercisable as follows: with respect to 1/4th of the shares subject to the option when the optionee completes 12 months of continuous service to the Issuer after the vesting commencement date, and with respect to 1/48th of the shares subject to the option when the optionee completes each month of continuous service to the Issuer thereafter. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 11:56 UTC |
Simpson CurranDirector · Chief Executive Officer
|
GrantCommon Stock | 56,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005567 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,785 F1 · shares: The restricted stock unit (RSU) award vesting commencement date shall be July 1, 2024. 1/4th of the shares subject to the RSU shall vest on each of the first, second, third and fourth anniversaries of the first day of the month in which the RSU was granted, subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 28, 2024 Filed Aug 5, 2024 18:38 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 1,363 | $9.95 | $13,555.04 |
DisclosureSEC source: 0001562180-24-006013 · primarydocument.xml · nonDerivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,216 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of January 1, 2024 through June 30, 2024. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 28, 2024. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:41 UTC |
Bennett JeanDirector
|
GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004652 · primarydocument.xml · derivative · entry 2 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:41 UTC |
Bennett JeanDirector
|
GrantCommon Stock | 4,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004652 · primarydocument.xml · nonDerivative · entry 1 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:43 UTC |
MIGAUSKY GEORGE VDirector
|
GrantStock Options (Right to Buy) · Derivative | 24,454 | $0.00 Strike: $14.35 | $0.00 |
DisclosureSEC source: 0001562180-24-004655 · primarydocument.xml · derivative · entry 2 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,454 Underlying: Common Stock · 24,454 shares Expires 2034-05-31 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.